Peter A. Crawford, MD, PhD
Crawford’s group is committed to understanding the metabolic origins of disease, particularly those rooted in overnutrition and maladaptive energy economy. Much of his interest proceeds through dissection of both the responses and influences of ketone body metabolism on nonalcoholic fatty liver disease progression, congestive heart failure, and cancer. The team leverages recent analytical chemical and computational advances in high-resolution mass spectrometry to perform both static and stable isotope tracing untargeted metabolomics, and also leverages magnetic resonance spectroscopy to quantify metabolic fate and flux. Advanced physiological phenotyping methodologies are strategically aligned with these chemical profiling platforms to generate resolved phenotypic pictures in genetically manipulated mouse models and in human participants.
Hosted by: Ethan Weiss, MD,
Contact: Aja Flores
The GICD/CVRI Seminar series is a collaborative series between the Gladstone Institute of Cardiovascular Disease and the Cardiovascular Research Institute at UC San Francisco.
Diversity, Equity, and Inclusion
At Gladstone, we are committed to providing events and professional development activities that resonate with our community’s diverse members. Our goal is to develop creative programming that encompasses a wide variety of ideas and perspectives to inspire, educate, and engage with everyone within our walls.
We want to effect positive change through our events and activities by providing a platform for discussions on important topics related to increasing diversity and inclusiveness in the sciences.